Here, our aims were two-fold: (1) to determine whether BVDV can adapt in vitro to circumvent the infection restriction imposed by the CD46 A82LPTFS receptor, and (2) to evaluate the infectivity of adapted BVDV isolates in primary cells from the CD46-edited heifer. Here, CD46 is linked to infection.